

No results matched your search
By Carl O'Donnell
(Reuters) - Pfizer Inc (NYSE:PFE) expects to deliver more than 13 million doses of its COVID-19 vaccine per week to the United States by the middle of March, more than doubling its shipments from early February, a top Pfizer executive said in prepared testimony ahead of a Tuesday congressional hearing.
Pfizer has shipped around 40 million doses to locations across the United States so far and is on track to deliver 120 million doses of its two-dose regimen by the end of March, said John Young, Pfizer's chief business officer.
He added that Pfizer is also prepared to provide a total of 300 million shots to the United States by the end of July and has raised global production expectations for 2021 to at least 2 billion doses.
In his own prepared remarks, Moderna (NASDAQ:MRNA) Inc President Stephen Hoge said the drugmaker plans to deliver 100 million doses of its two-dose shot by the end of March, and 300 million by the end of July.
Johnson & Johnson (NYSE:JNJ) believes it will be able to ship at least 20 million doses of its single-dose shot to the United States by the end of March after receiving U.S. regulatory authorization, said Vice President of Medical Affairs Richard Nettles. It expects to ship 100 million doses by mid-year 2021, it said.
The drugmakers’ remarks put the United States on track to receive 240 million doses by the end of March, enough to inoculate 130 million Americans, and 700 million doses by mid-year, more than enough to dose the entire U.S. population.
The comments were prepared ahead of a U.S. congressional hearing on vaccine availability to be held by the House Committee on Energy and Commerce on Tuesday.
By Josh Horwitz and Yilei Sun SHANGHAI (Reuters) -China's Alibaba (NYSE:BABA) does not expect any material impact from changes to its exclusivity arrangements with merchants,...
By Jessica DiNapoli (Reuters) - Most CEOs on a call to discuss a new push against U.S. state voting restrictions said in a poll they will reassess donating to candidates who fail...
By Wayne Cole SYDNEY (Reuters) -Asian shares faltered on Monday as investors wait to see if U.S. earnings can justify sky-high valuations, while bond markets could be tested by...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.